On Friday, Shares of Oncothyreon Inc (NASDAQ:ONTY), surged 20.30% to $2.43.
Oncothyreon, on May 11, stated a loss of $7.9 million in its first quarter.
On a per-share basis, the Seattle-based company said it had a loss of 8 cents. Losses, adjusted for non-recurring costs, came to 6 cents per share.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 8 cents per share.
Oncothyreon Inc., a clinical-stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of cancer. Its clinical-stage product candidates comprise ONT-380, an orally active and selective small-molecule HER2 inhibitor, which is in two Phase 1b trials, one in combination with Kadcyla and another in combination with Xeloda and/or Herceptin; and ONT-10, a therapeutic vaccine in Phase 1 trial targeting the Mucin 1 peptide antigen (MUC1) for use in various cancer indications, counting breast, thyroid, colon, stomach, pancreas, ovarian, and prostate, in addition to certain types of lung cancer.
Shares of Opko Health, Inc. (NYSE:OPK), inclined 1.44% to $16.92, during its last trading session, hitting its highest level.
OPKO Health, declared the online publication of a study entitled “A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort” in the journal European Urology. The study shows that the four kallikrein panel of biomarkers utilized in the OPKO 4Kscore® Test (Total PSA, Free PSA, Intact PSA and hK2) accurately identifies risk for aggressive prostate cancer preceding to prostate biopsy in a population of men referred for prostate biopsy based on Total PSA level and a Free PSA to Total PSA ratio.
The study evaluated the accuracy of the four kallikrein biomarkers in the 4Kscore together with age, DRE and an algorithm (4K algorithm) to predict risk of aggressive prostate cancer in a large community-based setting at Skåne University Hospital, Malmö, Sweden. Like the 4Kscore US Validation study, the Malmö study was conducted on men being referred for prostate biopsy, but in this study, the criteria for referral explicitly comprised of high-risk men with an elevated PSA (greater than or equal to 3 ng/mL) and a low percentage of Free PSA to Total PSA (less than or equal to 20%). These inclusion criteria selected for men with a higher risk for having aggressive prostate cancer than the cohort studied in the 4Kscore US Validation Study. Of the 749 men recruited for the trial, a total of 156 men (21%) were found to have aggressive prostate cancer defined as Gleason score greater than or equal to 7. The results demonstrated that the 4K algorithm discriminated men with aggressive prostate cancer from men who did not have aggressive disease with an area under the curve (AUC) of 0.78. The study also stated that even in this high risk patient population, a substantial number of biopsies (25%) could have been avoided. A decision curve analysis also demonstrated a noteworthy net benefit for the use of the 4K algorithm in this cohort contrast to performing biopsy on all men, the current standard of care.
OPKO Health, Inc., a biopharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies in the United States and internationally. It operates through two segments, Pharmaceuticals and Diagnostics.
At the end of Friday’s trade, Shares of Discovery Communications, Inc. (NASDAQ:DISCA), gained 1.13% to $31.75.
Intel Security, the world’s largest dedicated security technology company, in partnership with Discovery Education, the leading provider of digital content and professional development for K-12 classrooms nationwide, recently declared the winners of the Think Before You Link Sweepstakes. Part of the Intel®Security Digital Safety Program, a three-year national education initiative designed to teach children to “Think Before You Link” and make safer decisions when using the Internet, this sweepstakes awards more than $30,000 in cash prizes to deserving educators and elementary schools across the country in an effort to enhance students’ understanding of digital safety and awareness.
Educators, parents and community members nationwide were invited to enter in the Think Before You Link Sweepstakes on behalf of an elementary school of their choice by pledging their commitment to improve online safety awareness and guide recently’s students to become responsible digital citizens. The grand prize winner of the sweepstakes receives a $10,000 grant, second place winner receives a $5,000 grant and ten honorable mentions each receive a $1,000 grant to be used toward strengthening in-school digital safety awareness programs.
The grand prize and second place winning schools comprise:
- 1st Place: Namaqua Elementary School of Thompson School District R2-J in Loveland, Colo.
- 2nd Place: Oakcliff Elementary School of DeKalb County School District in Atlanta, Ga.
Discovery Communications, Inc. operates as a media company. The company operates through U.S. Networks; International Networks; and Education and Other segments. It owns and operates television networks under the brands, such as Discovery, TLC, Animal Planet, Investigation Discovery, Science, Velocity, Discovery Family, American Heroes, Destination America, Discovery Life, Oprah Winfrey network, Eurosport, DMAX, and Discovery Kids.
Finally, Real Goods Solar, Inc. (NASDAQ:RGSE), ended its last trade with -5.17% loss, and closed at $0.15, hitting its lowest level.
Real Goods Solar, has stated results for its first quarter ended March 31, 2015. The company also filed recently its quarterly report on Form 10-Q.
Q1 2015 Financial Summary
- In the first quarter of 2015, net revenue reduced 23% to $10.6 million from the preceding year quarter.
- Residential segment average selling price (ASP) on new sales orders rose 12.4% from the preceding year quarter and raised 4% from the fourth quarter of 2014. The enhance in ASP is primarily due to the company’s continued focus on pricing discipline.
- About 33% of the company’s revenue for the first quarter of 2014 was from two states, Missouri and Colorado, which formerly offered attractive incentives to homeowners. With the repeal of those incentives, the revenue from these states in the first quarter of 2015 was about 1% of revenue. The company grew its backlog in the East Coast since the preceding year quarter to offset this decline, but was hampered in converting that backlog into revenue by the inclement weather in the East Coast during the first quarter of 2015 and the limited access to solar panels.
- Progress on transformative initiatives:
- Sales orders for E-sales raised 8% to $2.6 million in the first quarter as compared to the same preceding year quarter.
- Sales orders for leasing reduced $1 million sequentially to $0.4 million in the quarter reflecting the company’s decision to optimize its use of working capital by originating leases for sale to third parties. There are no sales orders for leasing in the first quarter of 2014 given the leasing program was launched in the third quarter of 2014.
Real Goods Solar, Inc. operates as a residential and commercial solar energy engineering, procurement, and construction company in the United States. It operates in three segments: Residential, Sunetric, and Other. The company offers solar energy services, counting design, procurement, permitting, build-out, grid connection, financing referrals, and warranty and customer satisfaction.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
